#CDU;[1,1'-[6-[4-[[4-(4-(HYDROXYMETHYL)-PIPERIDIN-1-YL]-6-(4-HYDROXYPHENOXY)-1,3,5-TRIAZIN-2-YL]-OXY]-PHENOXY]-1,3,5-TRIAZINE-2,4-DIYL]-BIS-(PIPERIDINE-4,1-D
Compound with spectra: 1 NMR
![#CDU;[1,1'-[6-[4-[[4-(4-(HYDROXYMETHYL)-PIPERIDIN-1-YL]-6-(4-HYDROXYPHENOXY)-1,3,5-TRIAZIN-2-YL]-OXY]-PHENOXY]-1,3,5-TRIAZINE-2,4-DIYL]-BIS-(PIPERIDINE-4,1-D](/api/compound/BGIDLhiSS3j.png?ph=true&h=300&w=458 "#CDU;[1,1'-[6-[4-[[4-(4-(HYDROXYMETHYL)-PIPERIDIN-1-YL]-6-(4-HYDROXYPHENOXY)-1,3,5-TRIAZIN-2-YL]-OXY]-PHENOXY]-1,3,5-TRIAZINE-2,4-DIYL]-BIS-(PIPERIDINE-4,1-D")
| SpectraBase Compound ID | BGIDLhiSS3j |
|---|---|
| InChI | InChI=1S/C36H45N9O7/c46-21-24-9-15-43(16-10-24)31-37-32(44-17-11-25(22-47)12-18-44)39-34(38-31)50-29-5-7-30(8-6-29)52-36-41-33(45-19-13-26(23-48)14-20-45)40-35(42-36)51-28-3-1-27(49)2-4-28/h1-8,24-26,46-49H,9-23H2 |
| InChIKey | SDVGULCVXOHZBI-UHFFFAOYSA-N |
| Mol Weight | 715.8 g/mol |
| Molecular Formula | C36H45N9O7 |
| Exact Mass | 715.344195 g/mol |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
4-[4-(4-Cyclohexylphenoxy)-6-(4-morpholinyl)-1,3,5-triazin-2-yl]morpholine
3-Pyridazinol, 6-[[4-methoxy-6-(4-morpholinyl)-1,3,5-triazin-2-yl]oxy]-
2-Chloro-4-(4-chloro-3-methylphenoxy)-6-diethylamino-1,3,5-triazine
4-[4-Methoxy-6-[4-(4-methoxyphenyl)-1-piperazinyl]-1,3,5-triazin-2-yl]morpholine
2-Chloro-4-diethylamino-6-(3-trifluoromethylphenoxy)-1,3,5-triazine
N-[4-methoxy-6-(1-piperidinyl)-1,3,5-triazin-2-yl]-N-[4-(trifluoromethoxy)phenyl]amine
N-[4-[chloranyl-bis(fluoranyl)methoxy]phenyl]-4-methoxy-6-piperidin-1-yl-1,3,5-triazin-2-amine
4-(4-Benzyl-1-piperazinyl)-6-(4-morpholinyl)-1,3,5-triazin-2-yl 2,2,2-trifluoroethyl ether
(4-Methoxy-6-morpholino-S-triazin-2-yl)-[4-(trifluoromethoxy)phenyl]amine
DNRNUEZWXMYZBI-UHFFFAOYSA-N
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Biological Evaluation of Symmetrical 2,4,6-Trisubstituted 1,3,5-Triazine Derivatives | Chemical and Pharmaceutical Bulletin | 2013 |